Artificial intelligence is revolutionizing the early detection of arthritis and related diseases. A team at the University of Reading has secured £1.2 million in funding to develop a machine learning system named RMD-Health. This initiative aims to identify rheumatic and musculoskeletal diseases more effectively than current methods.
The project will be piloted at the Royal Berkshire NHS Foundation Trust and Oxford University Hospitals NHS Foundation Trust. By utilizing patient referral data, the system promises significantly higher accuracy in diagnosis, which could lead to improved patient outcomes and reduced healthcare costs. Collaboration with various healthcare stakeholders ensures a comprehensive approach to integrating AI into clinical practice.
• AI system RMD-Health aims to improve early detection of arthritis.
• Collaboration with hospitals enhances the accuracy of disease diagnosis.
The RMD-Health system utilizes machine learning to enhance the accuracy of arthritis detection.
The project introduces a machine learning-based decision support system to assist doctors in patient referrals.
The project focuses on early detection of RMD to improve treatment outcomes.
The University of Reading leads the RMD-Health project aimed at enhancing disease detection through AI.
The trust will pilot the RMD-Health system to improve early detection of rheumatic diseases.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.